MedDataX Logo

Turkish Acquired Haemophilia Registry

NCT ID: NCT01403740

Last Updated: 2011-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Turkish Acquired Haemophilia Registry is a database in which information about clinical features and therapeutic management of acquired haemophilia is collected in Turkey.This is a multicentre, retrospective and prospective registry of subjects diagnosed and/or treated for acquired haemophilia. Patients will be registered and the response to different therapies, details of each bleeding episode and the outcome of haemostatic and immunosuppressive therapy (IST) will be recorded. Any male or female subject diagnosed with inhibitors to FVIII or other factors and treated for acquired haemophilia can be entered on the registry. Patients will be treated according to local practice. No additional tests or procedures are required by the registry. The retrospective period will not be time-limited and data will be collected from those recorded in the hospital notes. The prospective period will begin in September 1.2011, and will last for two years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A

NCT02035384

Congenital Bleeding Disorder Haemophilia A
COMPLETED

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881

Haemophilia A Haemophilia A With Inhibitors Haemophilia B +1 more
COMPLETED

Long-term Anticoagulation in a Patient With Severe Hemophilia A

NCT07314983

Hemophilia A
RECRUITING

Combining Registry Data in Haemophilia: TARGET H

NCT03264014

Haemophilia
COMPLETED

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

NCT06574984

Congenital Bleeding Disorder Haemophilia A
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Haemophilia

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acquired haemophilia patients

rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin

Intervention Type DRUG

According to local clinical standards

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin

According to local clinical standards

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acquired haemophilia diagnosis, written consent

Exclusion Criteria

* Being unable to give written consent
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Turkish Society of Hematology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Turkish Society of Hematology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muzaffer A Demir, Prof

Role: PRINCIPAL_INVESTIGATOR

THD

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trakya University Haematology Clinic

Edirne, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dilek Solakoglu, MD

Role: CONTACT

[email protected]
902123253232

Volkan Aydin, MD

Role: CONTACT

[email protected]
902123253232

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Muzaffer A Demir, Prof

Role: primary

[email protected]
902842351041

Dilek Solakoglu, MD

Role: backup

[email protected]
902123253232

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011/HEM/001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
NCT03528551 COMPLETED PHASE3
Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients
NCT01817868 COMPLETED
Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A
NCT01125813 COMPLETED PHASE3
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 UNKNOWN
ATHNdataset Registry
NCT06820515 ENROLLING_BY_INVITATION
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
NCT01856751 UNKNOWN
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A
NCT01205724 COMPLETED PHASE1
Key Aspects of Medical Practice in Patients With Haemophilia A
NCT02996942 WITHDRAWN
Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds
NCT00486278 COMPLETED PHASE2
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
NCT02078427 COMPLETED
Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities
NCT04584892 COMPLETED
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 COMPLETED
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917 COMPLETED PHASE3
Swiss Hemophilia Registry
NCT02512250 RECRUITING
Register of Patients With haEmophilia A tReated With Afstyla®
NCT04675541 COMPLETED
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 COMPLETED
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
NCT04083781 ACTIVE_NOT_RECRUITING PHASE3
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 WITHDRAWN PHASE4
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
NCT03876301 COMPLETED
TFPI Levels in Haemophilia A and B Patients
NCT04570696 UNKNOWN
Clot Formation and Clot Stability in Patients With Severe Haemophilia A
NCT00279578 COMPLETED NA
Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting
NCT00950170 COMPLETED PHASE4
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
NCT04805021 RECRUITING
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
NCT03587116 COMPLETED PHASE3
Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)
NCT01341912 COMPLETED PHASE3